Stockscreener 앱 받기
1.57
2.48%
-0.04
시간 외 거래:
1.50
-0.07
-4.46%
전일 마감가:
$1.61
열려 있는:
$1.62
하루 거래량:
305.92K
Relative Volume:
0.71
시가총액:
$63.18M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-7.10%
1개월 성능:
+11.35%
6개월 성능:
-25.59%
1년 성능:
-75.16%
1일 변동 폭
$1.535
$1.64
1주일 범위
$1.46
$1.75
52주 변동 폭
$1.23
$8.1747
Metagenomi Inc Stock (MGX) Company Profile
명칭
Metagenomi Inc
전화
(510) 871-4880
주소
5959 HORTON STREET, EMERYVILLE
MGX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MGX
Metagenomi Inc
|
1.57 | 63.18M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
500.19 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
603.58 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
656.65 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
273.55 | 32.98B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
254.16 | 26.92B | 3.81B | -644.79M | -669.77M | -6.24 |
Metagenomi Inc Stock (MGX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-05-07 | 개시 | H.C. Wainwright | Buy |
| 2024-05-02 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-03-05 | 개시 | BMO Capital Markets | Outperform |
| 2024-03-05 | 개시 | Chardan Capital Markets | Buy |
| 2024-03-05 | 개시 | JP Morgan | Overweight |
| 2024-03-05 | 개시 | Jefferies | Buy |
| 2024-03-05 | 개시 | TD Cowen | Outperform |
| 2024-03-05 | 개시 | Wells Fargo | Overweight |
모두보기
Metagenomi Inc 주식(MGX)의 최신 뉴스
Renaissance Technologies LLC Has $555,000 Stock Holdings in Metagenomi, Inc. (NASDAQ:MGX) - Defense World
JPMorgan Chase & Co. Acquires 65,020 Shares of Metagenomi, Inc. (NASDAQ:MGX) - Defense World
Metagenomi Inc [MGX] stock for 1,744 USD was sold by Wein Matthew - knoxdaily.com
Metagenomi Inc: Navigating Market Volatility with a 1.79 Debt-to-Equity Ratio - investchronicle.com
Market Update: Metagenomi Inc (MGX) Sees Negative Movement, Closing at 1.49 - DWinneX
Metagenomi to Present at Upcoming Scientific Meetings - GlobeNewswire
Metagenomi to Present at Upcoming Scientific Meetings - GlobeNewswire Inc.
Press Release Distribution & PR Platform - ACCESS Newswire
Metagenomi Inc (NASDAQ: MGX)’s -10.37-Percent Loss Of This Past Week Taught Us Something New - Marketing Sentinel
Geode Capital Management LLC Has $2.12 Million Stock Position in Metagenomi, Inc. (NASDAQ:MGX) - Defense World
Metagenomi (MGX) versus Its Competitors Critical Analysis - Defense World
Mineralys, Tenaya, SpringWorks, COSCIENS, Metagenomi: 5 Biotech Stocks That Led Retail Follower Growth Last Week - MSN
Corebridge Financial Inc. Grows Position in Metagenomi, Inc. (NASDAQ:MGX) - Defense World
Metagenomi, Inc. Class Action Alert: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California against Metagenomi, Inc. - marketscreener.com
Sei Investments Co. Acquires New Stake in Metagenomi, Inc. (NASDAQ:MGX) - Defense World
Metagenomi, Inc. (NASDAQ:MGX) Shares Sold by Prudential Financial Inc. - Defense World
ATTENTION Metagenomi, Inc. Investors: You May Have Been Affected by FraudContact Levi & Korsinsky to Discuss Your Rights - ACCESS Newswire
Metagenomi Leads The Charge With These 3 Penny Stocks - simplywall.st
Can you still get a good price for Metagenomi Inc (MGX) Shares at this point? - uspostnews.com
Levi & Korsinsky Reminds Shareholders of an Investigation into Metagenomi, Inc. (MGX) Regarding Potential Securities Fraud Allegations - ACCESS Newswire
ATTENTION Metagenomi, Inc. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights - ACCESS Newswire
Q1 Earnings Forecast for Metagenomi Issued By HC Wainwright - The AM Reporter
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of November 25, 2024 in Metagenomi Lawsuit – MGX - ACCESS Newswire
MGX Investors Have Opportunity to Lead Metagenomi, Inc. Securities Fraud Lawsuit with the Schall Law Firm - marketscreener.com
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of November 25, 2024 in Metagenomi LawsuitMGX - ACCESS Newswire
HC Wainwright Lowers Metagenomi (NASDAQ:MGX) Price Target to $7.00 - Defense World
MGX stock plunges to 52-week low, hits $1.24 amid downturn - Investing.com Canada
Metagenomi Inc (MGX) 재무 분석
Metagenomi Inc (MGX)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.39%
3.66%
자본화:
|
볼륨(24시간):